Clinical Trials Logo

Borderline Personality Disorder clinical trials

View clinical trials related to Borderline Personality Disorder.

Filter by:

NCT ID: NCT02755181 Completed - Clinical trials for Borderline Personality Disorder

fMRI in Impulsivity

Start date: July 22, 2016
Phase:
Study type: Observational

This study aims to use resting-state and task based functional Magnetic Resonance Imaging (fMRI) as a tool to evaluate trait characteristics of impulsivity in subjects with borderline personality disorder.

NCT ID: NCT02752503 Recruiting - Clinical trials for Alcohol Use Disorder

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

Start date: March 2015
Phase: N/A
Study type: Interventional

The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.

NCT ID: NCT02728778 Completed - Clinical trials for Borderline Personality Disorder

Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)

BTX-BPD
Start date: September 1, 2016
Phase: Phase 2
Study type: Interventional

The main objective of the trial is to test whether a single application of botulinum toxin A into the glabellar region will lead to emotional stabilization in borderline personality disorder through paralysis of facial muscles/attenuation of negative emotions.

NCT ID: NCT02574429 Completed - Clinical trials for Posttraumatic Stress Disorder

CPT Group for DBT Clients With Co-Occurring Borderline Personality Disorder and PTSD

CPTDBT
Start date: April 2016
Phase: N/A
Study type: Interventional

Even though borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD) commonly co-occur, few studies have examined PTSD treatment among individuals with BPD. Additionally, many PTSD research studies exclude individuals with BPD due to their complexity and concerns regarding risk. This study aims to investigate the effectiveness of Cognitive-Processing Therapy Group (an evidenced-based treatment for PTSD) for individuals with these co-occurring disorders following completion of a Dialectical Behavioural Therapy Program (an evidenced-based treatment for BPD). The investigators are using a repeated measures pre and post design. Data will be collected prior to participants starting the CPT group, throughout the duration of the CPT group (i.e., weekly), and following the completion of the CPT group.

NCT ID: NCT02523664 Completed - PTSD Clinical Trials

Neural Correlates of Stress Hormones

Cort-fMRI
Start date: January 2014
Phase: N/A
Study type: Interventional

To investigate which neuronal correlates underlie cortisol-induced enhancement of memory retrieval in PTSD and BPD.

NCT ID: NCT02522143 Withdrawn - Suicide Clinical Trials

College Students Who Self-Harm

Start date: February 2014
Phase: N/A
Study type: Interventional

Study Aims/Objectives: This projects' Primary Aim is development of a Condensed DBT Stepped Care Model tailored to the unique requirements of students meeting sub-clinical diagnostic criteria for BPD (Borderline Personality Disorder) with its associated high rate of self-harm and suicide.

NCT ID: NCT02518906 Completed - Clinical trials for Borderline Personality Disorder

Evaluation of AIT Study

Start date: September 2015
Phase: N/A
Study type: Interventional

Specialized treatment of personality disorders (PD) in youth has been neglected for a long time, because these disorders were not diagnosed before the age of 18. Since 2013 the age threshold has been dropped in the Diagnostic and Statistical Manual (DSM)-5, and such change is also announced for the International Classification of Diseases (ICD)-11. There is broad consensus from both scientific evidence and clinical experience that specialized early interventions in adolescents with PD are urgently needed. In the last decades a number of specialized psychotherapeutic treatment programs have been developed. Despite their conceptual differences, many of the treatment models have shown significant effects in the treatment of PD in adults. However, the treatment of adolescents with PD remains difficult and further enhancement and development of treatments is needed. Given the different therapeutic approaches available, the present project aims to go beyond the comparison of integral therapeutic models in the classical outcome study design. While outcome research is important to build on the evidence of the effectiveness of an intervention, it contributes little to its understanding and refinement. The aim of the present multi-center project is to compare two therapeutic methods used in routine care: - Adolescent Identity Treatment (AIT) - Dialectic Behavioral Treatment for Adolescents (DBT-A) Treatments will be performed at different study centers and compared using the same measures of outcome. The main outcome will be psychosocial functioning. Additionally, the psychotherapy process will be investigated to explore specific and unspecific mechanisms of the therapeutic process, its outcome and mediators.

NCT ID: NCT02517723 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder

Start date: April 2014
Phase: N/A
Study type: Interventional

Narrative Exposure Therapy (NET) is an evidence-based trauma-focussed treatment, suitable for survivors of prolonged and repeated exposure to traumatic stress and childhood adversity. Patients with Borderline Personality Disorder (BPD) often suffer from a comorbid Posttraumatic Stress Disorder (PTSD) caused by multiple traumatic events. Therapeutic aims are the reduction of PTSD-Symptoms in these patients via activation of associative neural networks related to traumatic experiences and habituation of fear and the placement of traumatic experiences in a reconstructed, detailed and consistent autobiography. This practice enables the processing of and coping with painful memories and the construction of clear contingencies of dangerous and safe conditions, generally leading to significant emotional recovery. The investigators assume that using NET the reduction of PTSD symptom severity is greater compared to treatment by Dialectical-Behavioral Therapy (DBT).

NCT ID: NCT02465697 Completed - Clinical trials for Borderline Personality Disorders

Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions

Start date: September 2011
Phase: N/A
Study type: Interventional

Borderline Personality Disorder (BPD), a prevalent psychiatric disorder found in approximately 2% to 6% of the population and 20% of hospitalized psychiatric patients, has proven quite treatment resistant. This study is designed to determine whether patients with BPD can be trained to improve their ability to regulate their emotions and whether this leads to changes in how their brans regulate emotion.

NCT ID: NCT02397031 Completed - Clinical trials for Borderline Personality Disorder

Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder

Start date: September 2011
Phase: N/A
Study type: Interventional

The purpose of the study was to determine whether mindfulness training could be more effective than another active intervention in reducing borderline personality disorder (BPD) symptoms. The main hypothesis was that patients allocated to the mindfulness group would show a greater improvement on global BPD symptomatology. As a second objective, we explored some of the possible underlying mechanisms of both active treatments. For that purpose, changes in decentering, mindfulness facets and cognitive processing of social interactions were also evaluated.